The global coaching expert will enable EZRA to elevate its behavioral science-based research and solutions NEW YORK, May 23, 2023 /PRNewswire/ – EZRA, a leading virtual coaching provider, announces the appointment of world-renowned coaching academic, executive coach and published author…
Month: May 2023
Drills 120 AgEq g/t over 48.40 metres including 1,165 AgEq g/t over 0.33 metres VANCOUVER, BC, May 23, 2023 /PRNewswire/ – Avino Silver & Gold Mines Ltd. (TSX: ASM) (NYSE: ASM) (FSE: GV6), (“Avino” or “the Company”) releases the results of ten drill holes from below Level 17, the current…
LE PREMIER ESSAI CONTRÔLÉ RANDOMISÉ DE PHASE III SUR LA THÉRAPIE DE SHUNT AURICULAIRE RESTE PROMETTEUR TEWKSBURY, Massachusetts, 23 mai 2023 /PRNewswire/ — Corvia Medical, Inc, une société dédiée à la transformation du traitement de l’insuffisance cardiaque, a annoncé aujourd’hui les…
Pioneering platform to generate novel therapies with potential to treat a wide range of diseases Financing led by Science Creates Ventures and Meltwind to fund development of the platform and initial product candidates BRISTOL, England, May 23, 2023 /PRNewswire/ — Scarlet Therapeutics…
Leading industry expert with more than 25 years of experience in translation research in immunology BASEL, Switzerland, May 23, 2023 /PRNewswire/ — Engimmune Therapeutics AG (“Engimmune”), a Swiss biotech company developing novel T-cell receptor (TCR)-based therapeutics, is pleased to…
SEOUL, South Korea, May 23, 2023 /PRNewswire/ — KCI Ltd., a subsidiary of Samyang Group specializing in cosmetics and personal care materials, has been awarded ‘Gold Medal’ status in the 2023 Sustainability Rating from ‘EcoVadis,’ the world’s largest ESG rating organization. This…
FLORENCIA, Taliansko, 23. mája 2023 /PRNewswire/ — Spoločnosť A.Menarini Diagnostics S.r.l. s potešením oznamuje komerčné spustenie svojej platformy PRIME MDx: plne automatizovanej platformy molekulárnej diagnostiky od vzoriek k výsledkom, ktorá obsahuje všetko v jednom, na spracovanie…
FLORENCJA, Włochy, 23 maja 2023 r. /PRNewswire/ — A.Menarini Diagnostics S.r.l. z przyjemnością ogłasza wprowadzenie na rynek swojej platformy PRIME MDx: działającej w trybie „od próbki do wyniku”, kompleksowej i w pełni automatycznej platformy do diagnostyki molekularnej do…
ФЛОРЕНЦИЯ, Италия, 23 мая 2023 г. /PRNewswire/ — Компания A.Menarini Diagnostics S.r.l. сообщает о коммерческом запуске своей платформы PRIME MDx, которая представляет собой универсальную, полностью автоматизированную платформу молекулярной диагностики для обработки различных тестов с…
FLORENCIA, Italia, 23 de mayo de 2023 /PRNewswire/ — A.Menarini Diagnostics S.r.l. se complace en anunciar el lanzamiento comercial de su plataforma PRIME MDx: una plataforma de diagnóstico molecular totalmente automatizada, todo en uno y de muestra a resultado para el procesamiento de…